Bavarian Nordic A/S (BVNRY)
11.78
+0.30
(+2.61%)
USD |
OTCM |
Oct 09, 16:00
Bavarian Nordic Cash from Operations (Quarterly) : 55.02M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.02M |
| March 31, 2026 | -117.73M |
| December 31, 2025 | 84.43M |
| September 30, 2025 | 200.17M |
| June 30, 2025 | 183.17M |
| March 31, 2025 | -54.61M |
| December 31, 2024 | 139.85M |
| September 30, 2024 | -9.940M |
| June 30, 2024 | 91.04M |
| March 31, 2024 | 63.36M |
| December 31, 2023 | 83.35M |
| September 30, 2023 | 44.83M |
| June 30, 2023 | 64.09M |
| March 31, 2023 | -30.95M |
| December 31, 2022 | 30.48M |
| September 30, 2022 | 18.01M |
| June 30, 2022 | -21.22M |
| March 31, 2022 | 3.588M |
| December 31, 2021 | -17.26M |
| September 30, 2021 | 21.31M |
| June 30, 2021 | -41.73M |
| March 31, 2021 | -19.36M |
| December 31, 2020 | -61.32M |
| September 30, 2020 | 49.39M |
| June 30, 2020 | 35.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 63.70M |
| December 31, 2019 | -0.8436M |
| September 30, 2019 | -6.258M |
| June 30, 2019 | -23.48M |
| March 31, 2019 | -10.78M |
| December 31, 2018 | 1.578M |
| September 30, 2018 | 3.323M |
| June 30, 2018 | -16.41M |
| March 31, 2018 | -34.16M |
| December 31, 2017 | -24.96M |
| September 30, 2017 | -10.49M |
| June 30, 2017 | 44.26M |
| March 31, 2017 | 23.95M |
| December 31, 2016 | 95.66M |
| September 30, 2016 | -34.26M |
| June 30, 2016 | -11.77M |
| March 31, 2016 | -9.865M |
| December 31, 2015 | -25.07M |
| September 30, 2015 | -5.079M |
| June 30, 2015 | -44.64M |
| March 31, 2015 | 90.45M |
| December 31, 2014 | 98.41M |
| September 30, 2014 | -6.995M |
| June 30, 2014 | -16.48M |
| March 31, 2014 | -14.65M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Evaxion AS | -- |
| Genmab A/S | 51.04M |
| Ascendis Pharma A/S | 327.52M |
| Zealand Pharma A/S | 63.85M |
| Agenus, Inc. | -31.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -5.386M |
| Cash from Financing (Quarterly) | -36.42M |
| Free Cash Flow | 168.82M |
| Free Cash Flow Per Share (Quarterly) | 0.2061 |
| Free Cash Flow to Equity (Quarterly) | 48.36M |
| Free Cash Flow to Firm (Quarterly) | 47.77M |
| Free Cash Flow Yield | 6.17% |